SpiderRock Advisors’s Sanofi SNY Stock Holding History

SpiderRock Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Hold	–	-$4K	–	347
2017 Q3	–	Hold	–	–	–	542
2017 Q2	–	Hold	–	-$3K	–	1143
2017 Q1	–	Hold	–	–	–	1079

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SpiderRock Advisors's SNY Position: Q2 2024 in Review

SpiderRock Advisors sold out of Sanofi (SNY) in Q2 2024, closing a stake of 19,042 shares — an estimated $911K sold.

SpiderRock Advisors first reported a position in SNY in Q1 2024 and held it in 1 quarter. The position peaked at $911K in Q1 2024. 728 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

SpiderRock Advisors reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
SpiderRock Advisors sold 19,042 Sanofi shares in Q2 2024, an estimated $911K.
SpiderRock Advisors first reported a position in Sanofi in Q1 2024 and held it in 1 quarter.
SpiderRock Advisors's Sanofi position peaked at $911K in Q1 2024.
728 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on SpiderRock Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.